{
    "SPADE_N_13729": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13729",
            "Peptide Name": "cBD103 (Canine beta-defensin 103, natural AMPs; dogs, mammals, animals, 3S=S; UCSS1a)",
            "Source": "epithelium, nares,Canis lupus familiaris",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GIINTLQRYYCRIRSGRCALLSCLPKEEQIGRCSSTGRKCCRRKK",
            "Sequence Length": 45,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 5206.16,
            "PI": 10.1,
            "Hydrophobicity": -0.66,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Aono S, Dennis JC, He S, Wang W, Tao YX, Morrison EE. 2021",
                    "Reference": "Anat Rec (Hoboken). 2021 Jan;304(1):210-221. doi: 10.1002/ar.24300.PubMed",
                    "Title": "Exploring Pleiotropic Functions of Canine beta-Defensin 103: Nasal Cavity Expression, Antimicrobial Activity, and Melanocortin Receptor Activity."
                }
            ],
            "Frequent Amino Acids": "RCG",
            "Absent Amino Acids": "DFHMOUVW",
            "Basic Residues": 12,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 12,
            "Polar Residues": 30,
            "Positive Residues": 12,
            "Negative Residues": 2,
            "Net Charge": 10,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (84.78%) tohBD-3GRAVY: -0.65; Mol formula: C216H377N75O61S6; M. Wt:   5206.225, and Mol ex coeff.: 3355 (cys-paired). 3 disulfide bonds: Cys1–Cys5, Cys2–Cys4, Cys3–Cys6.Activity:  In rich medium, active against E-coli ATCC 25922, or resistant clinical strains (MIC>64 uM),  S-aureus ATCC 25923, MRSA (MIC>64 uM),  S. pseudintermedius clinical strain, no resistance (MIC 16 uM), S. pseudintermedius clinical strain, methicillin resistant MRSA (MIC 8 uM), P-aeruginosa ATCC 27853, P-hauseri ATCC 13315, E-faecalis clinical isolate (MIC >64 uM), E. faecium clinical isolate (MIC 8 uM). The peptide can kill nearly all the tested Gram+ and - bacterial strains in a minimal medium, indicating that medium components might have deactivated the peptide. Reg. 11/2021",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_13730",
                    "Similarity": 1.0,
                    "Sequence": "IINTLQRYYCRIRSGRCALLSCLPKEEQIGRCSSTGRKCCRRKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_25528",
                    "Similarity": 0.9,
                    "Sequence": "RGRKCCRRKKKCCKKP"
                },
                {
                    "SPADE_ID": "SPADE_N_08029",
                    "Similarity": 0.8666666666666667,
                    "Sequence": "MRIHYLLFALLFLFLVPVPGHGGIINTLQKYYCRVRGGRCALLSCLPKEEQIGKCSTRGRKCCRRKK"
                }
            ]
        }
    }
}